Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer
2018 ◽
Vol 81
(6)
◽
pp. 1043-1050
Keyword(s):
Phase Ii
◽